YTHDF1 gene polymorphisms and neuroblastoma susceptibility in Chinese children: an eight-center case-control study

Jiabin Liu,Jiwen Cheng,Li Li,Yong Li,Haixia Zhou,Jiao Zhang,Suhong Li,Huimin Xia,Jing He,Zhonghua Yang
DOI: https://doi.org/10.7150/jca.54496
IF: 3.9
2021-01-01
Journal of Cancer
Abstract:Neuroblastoma is one of the most common life-threatening extracranial tumors that mainly occurs in children, and its genetic etiology remains largely obscure. RNA m6A modification has been thought to play a key role in cancer progression. <i>YTHDF1</i> is the critical downstream gene by which RNA m6A modification exerts its functions. Single nucleotide polymorphisms in the <i>YTHDF1</i> gene may affect its expression and biological activity, thereby leading to abnormalities in the regulation of downstream m6A-modified RNA and eventually promoting the initiation and development of tumors. Here, we attempted to evaluate the contributions of two polymorphisms (rs6011668 C&gt;T and rs6090311 A&gt;G) in the <i>YTHDF1</i> gene to neuroblastoma susceptibility in 898 cases and 1734 controls that originated in China. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated in the logistic regression models to evaluate the associations between selected polymorphisms and neuroblastoma risk. Overall, either in a single locus or combination analysis, no significant association with neuroblastoma risk was found for either of the two selected polymorphisms. However, the stratified analysis showed that rs6090311AG/GG genotypes significantly reduced the neuroblastoma risk in males (adjusted OR=0.77, 95% CI=0.62-0.96, <i>P</i>=0.018). Moreover, we found that subjects with 2 protective genotypes had a lower tumor risk in males than in those with 0-1 protective genotypes (adjusted OR=0.77, 95% CI=0.62-0.96, <i>P</i>=0.018). In summary, our study indicates that <i>YTHDF1</i> gene polymorphisms may weakly contribute to neuroblastoma susceptibility. Our findings should be further verified by well-designed studies with larger sample sizes.
oncology
What problem does this paper attempt to address?